CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET ANALYSIS
Central Nervous System Biomarkers Market – Regional Analysis
On the basis of region, the global central nervous system biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America central nervous system biomarkers market is expected to show significant growth, owing to expansion activities by key players in the region. For Instance, in January 2017, bioMérieux, an in vitro diagnostics company, entered into a partnership with Banyan Biomarkers. Banyan Biomarkers develops, validate, and market blood-based biomarkers for traumatic brain injury. Under this agreement, bioMérieux took an equity participation of around US$ 7 million in Banyan Biomarkers and also obtained rights to develop market for Banyan’s proprietary tests worldwide.
Increasing prevalence of Alzheimer’s disease is expected to drive growth for the central nervous system biomarkers market in Asia Pacific. For instance, according to Alzheimer's Disease International (ADI), in 2015, around 23 million people in Asia Pacific suffered from dementia.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
